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We present a short summary of recent observations on the glo-
bal distribution of the major clades of the Mycobacterium tuber-
culosis complex, the causative agent of tuberculosis. This
global distribution was defined by data-mining of an interna-
tional spoligotyping database, SpolDB3. This database con-
tains 11,708 patterns from as many clinical isolates originating
from more than 90 countries. The 11,708 spoligotypes were
clustered into 813 shared types. A total of 1,300 orphan pat-
terns (clinical isolates showing a unique spoligotype) were also
detected. 
ince the publication of the second version of our spoligo-
types database on Mycobacterium tuberculosis (1), the
causative agent of tuberculosis (TB), the proportion of clus-
tered isolates (shared types [STs]) increased from 84% (2,779/
3,319) to 90% (11,708/13,008). Fifty percent of the clustered
isolates were found in only 20 STs. Three of these isolates are
M. bovis, including M. bovis BCG (ST 481, 482, and 683). The
addition of the next 30 most frequent STs increased the total
proportion of clustered isolates (65% instead of 50% initially).
A total of 36 potential subfamilies or subclades of M.
tuberculosis complex have been tentatively identified, leading
to the definition of major and minor visual recognition rules
(Table). The ancestral East-African Indian family (EAI) is
made up of at least five main subclades, whereas at least three
major spoligotyping patterns are found within the Haarlem
family (2). Two families found in central and Middle Eastern
Asia (CAS1 and CAS2) are newly defined. The X family (3) is
also currently split into at least three well-defined subclades.
However, the subdivision of family T (T1–T4, likely to repre-
sent relatively old genotypes), which differs from the classic
ST 53 (all spacers present except 33–36), remains poorly
defined. Similarly, the Latino-American and Mediterranean
family (LAM) is tentatively split into subclades LAM1–
LAM10 (4). Spoligotyping used alone is not well suited for
studying the phylogeny of these two clades (T and LAM).
Such study will require results from other genotyping methods
such as IS6110-restriction fragment length polymorphism (5)
or mycobacterial interspersed repetitive units–variable number
of DNA tandem repeats (6). Among well-characterized major
clades of tubercle bacilli, four families represent 35% of
11,708 clustered isolates (Beijing 11%, LAM 9.3%, Haarlem
7.5%, and the X clade 7%).
The global distribution of the most frequently observed
spoligotypes by continent in SpolDB3 is as follows. Among
the patterns originating in North America (n= 4,276, 32% of
the total number of isolates in the database), 16% of the strains
are of the Beijing type, 14% belong to ST 137 or ST 119 (X
family), and 8% are unique (results not shown). In Central
America (n=587, 4.5%), 8% of the strains belong to the ubiq-
uitous ST 53, 7% are ST 50, and 6% are ST 2; the last two STs
are part of the Haarlem family. In South America (n=861,
6.6%), the distribution of ST 53 and ST 50 accounts for 10%
and 9%, respectively, of the spoligotypes, whereas ST 42
accounts for as much as 9% of the total isolates. The origin of
ST 42 remains to be established. In Africa (n=1,432, 11%), ST
59 and ST 53 account for 9% of all isolates studied thus far;
however, the values obtained for ST 59 are biased because
strains from Zimbabwe are overrepresented. We also observed
that M. africanum ST 181 accounts for as much as 6% of all
spoligotypes from Africa in our sample. 
In Europe (n=4,360, 33.5%), ST 53 represents as much as
9% of the spoligotypes, ST 50 and 47 (Haarlem family) repre-
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Table. Excerpt from SpolDB3 database showing prototype spoligotypes, visual recognition rules, and binary and octal descriptiona
Rk ST Classb Total (n)c Rulesd Binary description Octal
1 1 Beijing 1282 ∆1–34 ??????????????????????????????????????????? 000000000003771
2 53 T1 864 F ??????????????????????????????????????????? 777777777760771
11 52 T2 163 ∆40 and F ??????????????????????????????????????????? 777777777760731
30 37 T3 71 ∆13 and F ??????????????????????????????????????????? 777737777760771
64 40 T4 26 ∆19 and F ??????????????????????????????????????????? 777777377760771
7 47 Haarlem1 246 ∆26–30 and E ??????????????????????????????????????????? 777777774020771
20 2 Haarlem2 104 ∆1–24, ∆26–30 and E ??????????????????????????????????????????? 000000004020771
3 50 Haarlem3 519 E ??????????????????????????????????????????? 777777777720771
6 119 X1 310 C ??????????????????????????????????????????? 777776777760771
4 137 X2 427 C and ∆39–42 ??????????????????????????????????????????? 777776777760601
31 92 X3 70 ∆4–12 and C ??????????????????????????????????????????? 700036777760731
15 48 EAI1 118 A and ∆40 ??????????????????????????????????????????? 777777777413731
13 19 EAI2 130 ∆3, ∆20–21 and A ??????????????????????????????????????????? 677777477413771
16 11 EAI3 121 ∆2-3, A and ∆37–39 ??????????????????????????????????????????? 477777777413071
8 139 EAI4 234 ∆26–27 and A ??????????????????????????????????????????? 777777774413771
46 236 EAI5 41 A ??????????????????????????????????????????? 777777777413771
24 181 Afri1 91 ∆7–9 and ∆39 ??????????????????????????????????????????? 770777777777671
ND 331 Afri2 9 ∆8–12, ∆21–24 and ∆37–39 ??????????????????????????????????????????? 774077607777071
ND 438 Afri3 3 ∆8–12 and ∆37–39 ??????????????????????????????????????????? 774077777777071
17 482 M. bovis-BCG 26 ∆3, ∆9, ∆16 and D ??????????????????????????????????????????? 676773777777600
ND 641 M. microti 8 4-7, 23–24, 37–38 ??????????????????????????????????????????? 074000030000600
ND 592 M. canetti 6 30 and 36 ??????????????????????????????????????????? 000000000101000
21 26 CAS1 102 ∆4–7, ∆23–34 ??????????????????????????????????????????? 703777740003771
ND 288 CAS2 6 ∆4–10, ∆23–34 ??????????????????????????????????????????? 700377740003771
12 20 LAM1 152 ∆3 and B ??????????????????????????????????????????? 677777607760771
22 17 LAM2 92 ∆3, ∆13 and B ??????????????????????????????????????????? 677737607760771
19 33 LAM3 108 ∆9–11 and B ??????????????????????????????????????????? 776177607760771
49 60 LAM4 37 ∆40 and B ??????????????????????????????????????????? 777777607760731
42 93 LAM5 44 ∆13 and B ??????????????????????????????????????????? 777737607760771
37 64 LAM6 47 ∆29 and B ??????????????????????????????????????????? 777777607560771
36 41 LAM7 48 ∆20, ∆26-27 and B ??????????????????????????????????????????? 777777404760771
NA 290 LAM8 9 ∆27 and B ??????????????????????????????????????????? 777777606760771
5 42 LAM9e 344 B ??????????????????????????????????????????? 777777607760771
9 61 LAM10 202 ∆23–25 and F ??????????????????????????????????????????? 777777743760771
26 34 Sf 82 ∆9–10 and F ??????????????????????????????????????????? 776377777760771
28 451 H37Rv 78 ∆20–21 and F ??????????????????????????????????????????? 777777477760771
aRk, ranking no.; ND, not done; ST, arbitrary designation; M., Mycobacterium.
bClass: family definition. See text for the definition of the family acronyms.
cTotal (n), size of the class; binary and octal, description.
dRule A, absence of spacers 29–32, presence of spacer 33 and absence of spacer 34; rule B, absence of spacers 21–24 and spacers 33–36; rule C : absence of spacer 18 and spacers 33–
36; rule D, absence of spacers 39–43; rule E, absence of spacer 31 and spacers 33–36; rule F, absence of spacers 33–36. Clades defined with low sample size, such as Afri2, Afri3, 
CAS2, and LAM8 are subject to change.
eFormerly LAM1.
fFormerly LAM2
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sent 8% of the cases, and the Beijing family accounts for 4%
of the spoligotypes. In the Middle Eastern and central Asian
region, where the number of samples obtained is still very low
(n=351, 2.7%), a high diversity of strains within the EAI and
CAS families has been observed, and no single pattern cur-
rently exceeds 5%. Further studies of isolates from these
regions are needed, e.g., in India, where our sampling is still
anecdotal (n=44 isolates). Notwithstanding the scarcity of
available data from this region, the observed diversity suggests
that this region might be of great interest for further study of
the genetic variation of tubercle bacilli. Contrary to what we
observed for the Middle East and central Asia, the Far East
Asian region (n=801, 6.1%) is characterized by the prevalence
of a single genotype, the Beijing type family, a family linked
to emerging multiresistance (7). One out of two strains in the
Far East is a Beijing type. In Oceania (n=340, 2.6%), ST 19
and Beijing account for 15% and 13%, respectively, of clus-
tered isolates. Thus, this preliminary analysis of the spoligo-
type distribution of SpolDB3 clearly shows major differences
in the population structure of tubercle bacilli within the eight
subcontinents studied (Africa; Europe; North America; Cen-
tral America; South America; Middle East and Central Asia;
Far East Asia; and Oceania). 
At present, SpolDB 3 is an experimental tool that has yet
to prove its usefulness in tracking epidemics. Nevertheless, the
facility with which matches between spoligotypes can be
detected suggests that this tool may be a good screening mech-
anism for population-based studies on recent TB transmission.
Indeed, the detection of a rarely found ST in SpolDB3 may be
a catalyst that signals researchers to look for the clonality of
the isolates and to study their epidemiologic relatedness.
Data-exchange protocols through inter-networking will
also be implemented in the near future. Working groups such
as the European Network for Exchange of Molecular Typing
Information (available from: URL: www.rivm.nl/enemti) are
coordinating such initiatives. The expanded use of the Bionu-
merics software (third upgrade; Applied Maths, St. Martens-
Latem, Belgium) may also foster this research field. SpolDB3
will also be instrumental in facilitating better understanding of
the driving forces that shape tubercle bacilli evolution. Further
research should now emphasize the use of data-mining meth-
ods, in combination with experts’ knowledge, to tackle the
complex dynamics of the population's genetics of tubercle
bacilli and TB transmission (3). Our sample represents the
compilation of many national studies and, as such, should be
considered as an ongoing population-based project aimed at
studying global TB genetic diversity. Nevertheless, obtaining a
more precise and representative snapshot of the genetic vari-
ability of M. tuberculosis complex will require a larger sam-
pling. Although only partially representative of worldwide
spoligotypes of M. tuberculosis complex, Spo1DB3 contains a
reservoir of genetic information that has already proved useful
for defining the phylogenetic links that exist within the TB
genomes and for constructing theoretical models of genome
evolution. Much remains to be done to evaluate the potential
of global genetic databases to better characterize casual con-
tacts (that could lead to identification of sporadic cases) in TB
epidemiology. An improved version of our database, which
will focus on areas with a high prevalence of TB, is currently
in development; as of August 26, 2002, it had 20,000 isolates
and 3,000 alleles. Ongoing population-based genotyping
projects will likely help shed light on contemporary and
ancient tubercle bacilli’s evolutionary history.
This paper was written as part of the EU Concerted Action
project QLK2-CT-2000-00630 and partly supported by the Réseau
International des Instituts Pasteur et Instituts Associés, Institut Pas-
teur and Fondation Française Raoul Follereau, France. An electronic,
simplified, version of SpolDB3 is available from the corresponding
authors upon request. 
Dr. Filliol performed this work as part of her doctoral thesis. She
has been working at the Institut Pasteur de Guadeloupe for the last 4
years. Her research focuses on molecular epidemiology and phylog-
eny of tubercle bacilli.
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